KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Novavax (NVAX) Preferred Shares Issued (2020)

Novavax has reported Preferred Shares Issued over the past 1 years, most recently at $200.0 million for Q2 2020.

  • Quarterly results put Preferred Shares Issued at $200.0 million for Q2 2020, changed N/A from a year ago — trailing twelve months through Dec 2021 was $200.0 million (changed N/A YoY), and the annual figure for FY2020 was $199.8 million, changed.
  • Preferred Shares Issued for Q2 2020 was $200.0 million at Novavax.
  • Over the last five years, Preferred Shares Issued for NVAX hit a ceiling of $200.0 million in Q2 2020 and a floor of $200.0 million in Q2 2020.